From: HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study
 | Controls | Squamous cell carcinoma | Adenocarcinoma | ||||
---|---|---|---|---|---|---|---|
 | Number | Number | OR | 95% CI | Number | OR | 95% CI |
HIV | Â | Â | Â | Â | Â | Â | Â |
   Any (+or-) | 54 | 183 |  |  | 26 |  |  |
   Negative | 35 | 142 | 1.0 (ref) |  | 24 | 1.0 (ref) |  |
   Positive | 19 | 41 | 0.7 | 0.3-1.4 | 2 | 0.2 | 0.04-0.8 |
CD4 count | Â | Â | Â | Â | Â | Â | Â |
   Any | 37 | 135 |  |  | 21 |  |  |
   >300 | 33 | 113 | 1.0 (ref) |  | 19 | 1.0 (ref) |  |
   ≤300 | 4 | 22 | 1.8 | 0.6-6.2 | 2 | 1.8 | 0.3-10.1 |
   >500 | 26 | 90 | 1.0 (ref) |  | 15 | 1.0 (ref) |  |
   ≤500 | 11 | 45 | 1.4 | 0.6-3.3 | 6 | 0.9 | 0.3-3.1 |